LUNG NON-SMALL CELL CARCINOMA
Clinical trials for LUNG NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Light and immune combo shows promise in tough lung cancers
Disease control TerminatedThis early-phase study tested a treatment that uses a light-activated drug (photodynamic therapy) plus immunotherapy to fight non-small cell lung cancer with pleural spread or malignant pleural mesothelioma. Only 5 people took part before the study ended early. The main goal was …
Matched conditions: LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 17, 2026 03:14 UTC
-
Experimental combo aims to reboot immunotherapy in stubborn lung cancer
Disease control TerminatedThis small pilot study tested whether adding a special type of radiation called grid therapy could help the immunotherapy drug durvalumab work again in patients with non-small cell lung cancer that had stopped responding to the standard PACIFIC regimen. Only 4 patients were enrol…
Matched conditions: LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 03:09 UTC